Related Experiment Video
Updated: Oct 11, 2025

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
Ending tuberculosis in China: health system challenges
Qian Long1, Lei Guo2, Weixi Jiang1
1Global Health Research Center, Duke Kunshan University, Jiangsu, China.
The Lancet. Public Health
|November 28, 2021
Summary
China has significantly reduced tuberculosis (TB) but faces challenges in its integrated TB control program. Addressing profit-driven practices and improving coordination are crucial for achieving the WHO End TB Strategy goals.
Area of Science:
- Public Health
- Health Systems Research
- Infectious Disease Control
Background:
- China has achieved substantial reductions in tuberculosis (TB) incidence and mortality over the past 30 years.
- Despite progress, the nation has not met the targets of the World Health Organization (WHO) End TB Strategy.
- Efforts since the 2000s to integrate the TB control program, transitioning from a vertical model led by the Chinese Center for Disease Control and Prevention (CDC), have encountered significant obstacles.
Purpose of the Study:
- To analyze the challenges hindering the effective integration of China's tuberculosis control program.
- To identify key factors impacting the quality, accessibility, and affordability of TB care within the evolving health system.
- To provide recommendations for policy dialogue and multi-level coordination to accelerate TB elimination efforts.
Main Methods:
- The study likely involved a review of China's TB control policies and health system reforms.
- Analysis of the operational dynamics between the CDC, designated TB hospitals, and primary health centers.
- Examination of financial incentives, professional training, and administrative structures influencing TB service delivery.
Main Results:
- Profit-driven practices in TB-designated hospitals compromise care quality.
- Inadequate TB-related training for healthcare professionals affects service delivery.
- Primary healthcare providers lack incentives for effective patient referral and management.
- The CDC's limited administrative authority restricts its ability to influence hospital practices and resource allocation.
- Lack of policy coherence and coordination impedes affordable and accessible TB care.
Conclusions:
- Successful TB elimination in China requires addressing systemic challenges within the integrated control program.
- Improving policy dialogues and enhancing multi-level governmental coordination are fundamental.
- These strategies are also relevant for other countries striving to end tuberculosis.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
264
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
264
Pulmonary Tuberculosis I
391
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
391
Pulmonary Tuberculosis IV
227
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
227
Pulmonary Tuberculosis II
616
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
616
Pulmonary Tuberculosis III
508
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
508
Other Pulmonary Disorders
957
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
957

